Novo Nordisk Pharmaceuticals (Philippines), Inc.
21F Twenty-Four Seven Mckinley Building, 24th Street corner 7th Avenue, Bonifacio Global City, Fort Bonifacio, Taguig City, Philippines
E-mail: NNPPISafety@novonordisk.com
Phone: +632 8234 3500
You can always contact Novo Nordisk Philippines or the Novo Nordisk Data Privacy Officer at privacyph@novonordisk.com with questions or concerns about how we process your personal data.
- From you directly
- From your family members or care givers on your behalf
- From Health Care Professionals such as your nurse, a pharmacist or doctor
- Through phone calls, emails and other digital channels
- To perform scientific evaluations of complaints and side effects potentially related to Novo Nordisk’s medicinal products. Complaints and side effects will be filed in databases and will be regularly analysed for overall patterns.
- To respond to your questions or request for information
- To analyse data for the purpose of supporting product usage enquiries
- To analyse data for the purpose of improving our customer service and product offerings
- To analyse data for the purpose of improve our scientific and product communication to HCPs and patients
- To assess patterns and trends associated with complaints, side effect and product usage
- Contact information (name, address, telephone number, email address);
- Data revealing racial or ethnic origin;
- Data concerning health and medicinal products you are using;
The processing is necessary for our legitimate interests. The legitimate interests are:
a. The processing is necessary for our compliance with a legal obligation
b. To perform scientific evaluations of complaints and side effects potentially related to Novo Nordisk’s medicinal products.
c. To improve our customer service and product offerings
d. To enhance our scientific and product communication
e. You gave consent for us to process your personal data
- Suppliers or vendors that assist our company (e.g., consultants, IT service providers, financial institutions, law firms, license partners)
- Other Novo Nordisk entities (e.g., Novo Nordisk affiliates in other countries)
- Public authorities, including health and/or regulatory authorities
- Other pharma companies and partners if an enquiry is related to their product(s)
We have safeguards in place to secure your personal data when transferred outside of the European Economic Area (EEA).
Situation | Safeguards protecting your data |
Data is transferred from Novo Nordisk entity in EEA to Novo Nordisk entity outside EEA | Protected by Novo Nordisk’s Binding Corporate Rules, available at https://www.novonordisk.com/content/dam/nncorp/global/en/data-privacy/novo-nordisk-binding-corporate-rules.pdf |
Data is transferred from Novo Nordisk entity in EEA to third country | Protected by Standard Contractual Clauses for the transfers of data to third countries entered into by Novo Nordisk. Or, adequate data protection is in place in destination country according to EU commission |
- For data relating to technical complaints: 12 years
- For safety information and data relating to side effects: End of activity + 10 years, where end of activity is the time where no product with the active ingredient is marketed
- For all other enquiries: Up to 5 years
Your rights | How you exercise your rights |
Overview of your data | Ask for a copy of your personal data, which we provide in a structured format, readable to a machine |
Restrict use | Request that we stop or limit the use of your personal data |
Deletion | Request that your personal data is anonymised |
Correct your data | Ask us to correct information about you |
Complain about our use of the data | Submit a complaint to your local Data Protection Authority |
Under applicable law, there may be limits on these rights depending on the specific circumstances of the processing activity. Contact us as described in Section 1 with questions or requests relating to these rights.